Pagoda Capital
Global perspective.
China opportunity.
Capturing onshore & cross-border opportunities in China healthcare.
Explore our portfolioConnecting global innovation
with China’s potential.
Founded in 2015, Pagoda Capital is a private equity firm with an established onshore and cross-border investment platform focused on China growth in Healthcare and Technology.
Meet our teamA closer look at our portfolio
ICON
ICON
No. 1 integrated oncology care provider in Asia-Pacific
ICON Group is the No. 1 comprehensive cancer service provider in the Asia-Pacific region, with 17 years of operating experience, with more than 40 precision tumor treatment centers in China, Australia, New Zealand, Singapore, and Hong Kong;
Together with Goldman Sachs and QIC, Pagoda Capital formed a consortium and completed the shareholding acquisition in 2017. It aims to use China's abundant resources to cooperate with hospitals and groups to expand the Chinese business ecosystem through the model of joint investment, construction and operation of high-quality cancer treatment centers.
Synthego
Synthego
World leading CRISPR technology provider for DNA editing
Synthego is the world's leading gene editing company, providing research scholars and industries with synthetic guide RNA and automated scientific workflows for CRISPR gene editing;
In just 2 years, gRNA products have become one of the market leaders in the United States and the European Union
Momenta
Momenta
Top-notch deep-learning based software for autonomous driving
Epic Sciences
Epic Sciences
One of the most advanced CTC diagnostic platforms
Experience that makes
the difference.
Healthcare expertise. Investment experience. A shared commitment to building value.
Meet our team